POLYPLUS-TRANSFECTION

Polyplus has been driven to innovate solutions for nucleic acid delivery that power your science since January 2001. Originally named Polyplus-transfection, the company shortened the name to Polyplus in 2022, as we began to expand our focus on building our portfolio of purpose fit solutions and services that help customers optimize upstream process economics... Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services.

Also known as: Polyplus Inc, Polyplus-transfection SA, Polyplus®

Primary location: Illkirch France